HMHugh Mulcahy

Hugh Mulcahy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hugh Mulcahy has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation

    by Darragh Storan, Edel McDermott, Jenny Moloney, Lisa Keenan, Roisin Stack, Juliette Sheridan, Glen Doherty, Garret Cullen, Louise McHugh, Hugh E Mulcahy

    Objective The Inflammatory Bowel Disease Disability Index (IBD-DI) was developed according to WHO standards and has been validated in population-based cohorts. However, there are limited data on its relationship to various psychosocial and economic variables or its relevance to hospital clinical practice. The study aims were to determine the validity and reliability of the IBD-DI in an English-speaking hospital out-patient population and to evaluate its association with short and long-term disease activity. Design/Methods 329 subjects were enrolled in a cross-sectional and longitudinal study assessing the IBD-DI and a range of quality of life, work impairment, depression, anxiety, body image, interpersonal, self-esteem, disease activity, symptom scoring scales in addition to long-term outcome. Results The IBD-DI had adequate structure, was internally consistent and demonstrated convergent and predictive validity and was reliable in test–retest study. Disability was related to female sex (p=0.002), antidepressant use (pConclusion The IBD-DI is a valid and reliable measure of disability in English-speaking hospital populations and predicts long-term requirement for treatment escalation.


  • Open Access

    Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model study

    by Roisin Stack, Jayne Doherty, Neil O'MOráin, Blathnaid Nolan, Juliette Sheridan, Garret Cullen, Hugh Mulcahy, Maire Buckley, Gareth Horgan, Mohamed Hamed, et al.

    Objective To evaluate the impact of British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England (BSG/ACPGBI/PHE) 2019 polypectomy surveillance guidelines within a national faecal immunochemical test-based bowel cancer screening (BS) cohort on surveillance activity and detection of pathology by retrospective virtual application. Design A retrospective review of BS colonoscopies performed in 2015–2016 with 5 years prospective follow-up in single institution. Index colonoscopies were selected. Incomplete colonoscopies were excluded. Histology of all resected polyps was reviewed. Surveillance intervals were calculated according to BSG/ACPGBI/PHE 2019 guidelines and compared with pre-existing ‘European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis’ (EUQA 2013). Total number of colonoscopies deferred by virtual implementation of BSG/ACPGBI/PHE 2019 guidelines were calculated. Pathology identified on procedures that would have been deferred was reviewed. Results Total number of index BS colonoscopies performed in 2015–2016 inclusive was 890. 115 were excluded (22 no caecal intubation, 51 inadequate bowel preparation, 56 incomplete polyp clearance). N=509 colonoscopies were scheduled within a 5-year interval following index colonoscopy surveillance rounds based on EUQA guidelines. Overall, volume of surveillance was significantly reduced with retrospective application of BSG/ACPGBI/PHE 2019 guidelines (n=221, pConclusion BSG/ACPGBI/PHE 2019 guidelines safely reduce the burden of colonoscopy demand with acceptable pathology findings on deferred colonoscopies.


  • Tu1790 COMBINATION BIOLOGIC OR SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE

    by Catherine Mcshane, Rachel Varley, Anne Fennessy, John R. Campion, Karl Hazel, Eabha Ring, Alan Marrinan, Conor Palmer, Aine Keogh, Clodagh Byron, et al.

  • Endoscopic and Histological Gastritis: Less Than Meets the Eye

    by A. Gallagher, Z. Al Abri, A. Al Badaai, M. Al-Saad, M. Al-Hinai, M. Al-Rashdi, M. Hamed, H. Mulcahy

    Aims Gastritis is a histological diagnosis of inflammation of the gastric mucosa1. When referred for endoscopy it is often reported at time of gastroscopy, prior to confirmation on biopsy. We aimed to assess endoscopic versus histological diagnosis of gastritis. Methods We performed a single centre retrospective analysis over a two-year period. Endoscopic electronic results were compared to histopathology reports [1]. Results Two thousand three hundred and thirty patients were diagnosed with Gastritis at endoscopy. Sixty seven percent of patients (n=1558) had gastric biopsies taken at time of procedure. Eight occurred in the presence of a new diagnosis of cancer and were excluded. Of the remaining population fourty three percent (n=674) had gastritis on biopsy. Fifty seven percent (n=876) of endoscopic diagnoses of gastritis were not confirmed histologically. Although trainees performed more biopsies than consultants (69% versus 59%) there was no discrepancy between rates of histology confirmation (41% versus 43%). One hundred and seven patients with histological gastritis also had Intestinal Metaplasia, fifty three percent of which had biopsies taken from more than one site. Of the nine patients with dysplasia -8 low grade and 1 high grade-only two patients did not have a clinical suspicion documented at time of endoscopy. It is unclear why thirty three percent of patients did not have biopsies, but it was not dependent on patient age, gender or seniority of endoscopist ([Fig. 1]). Conclusions These findings suggest clinical practice is extremely varied and recommendations are required for biopsies in patients with suspected gastritis. Gastritis Flowchart Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • A comparison of colorectal polyp detection in average-risk FIT +ve screening and age-controlled symptomatic cohorts

    by N. O'MOrain, P. Girod, L. Kumar, M. Mccrossan, O. Casey, E. Joy, G. Horgan, H. Mulcahy, G. Doherty

    Aims Colonoscopy is a finite resource. There are two main pathways of referral in Ireland; a population based screening programme (60-69y) and symptomatic patients. The aim of this study was to evaluate the findings of advanced colorectal polyps and cancer in this age group. Methods A single centre age-controlled retrospective observational study from January 2015 to December 2021 was performed. All index colonoscopies performed on patients aged 60-70 years old were included. FIT cut off was 45ugHb/gF. Diagnostic yield was reported as the adenoma detection rate (ADR), SSL detection rate (SSLDR), detection of an advanced adenoma/serrated lesion, high-grade dysplasia, or adenocarcinoma. Quality measures including adequacy of bowel preparation and use of hyoscine butylbromide were recorded. [1] [2] [3] Results 5941 colonoscopies were included; 2619 (44.1%) were FIT +ve. The median age was 65 years [IQR 62-68], with females predominant in both groups (52.8% and 57.9%). There were significant differences in ADR (57.5% vs 25.4%, p<0.01), SSLDR (10.7% vs. 6.2%, p<0.01), advanced polyps (22.1% vs. 5.9%, p<0.01), HGD (4.9% vs. 0.8%, p<0.01) and cancer detection (4.8% vs. 0.9%). Better bowel preparation (83.5% vs. 71.3%, p<0.01) and increased use of hyoscine butylbromide (19.2% vs. 3.9%, p<0.01) was noted in the screening group ([Table 1]). Conclusions The screening programme yields significantly more pathology than the symptomatic group. Better triage of symptomatic patients to a FIT-based pathway may increase the utility of this scarce resource in this age group. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies

    by Joseph Lavelle, Darragh Storan, Varsha Eswara Murthy, Noemi De Dominicis, Hugh E. Mulcahy, Louise McHugh

    Psychological intervention targeting distress is now considered an integral component of inflammatory bowel disease (IBD) management. However, significant barriers to access exist which necessitate the development of effective, economic, and accessible brief and remote interventions. Acceptance and commitment therapy (ACT) is a therapy with demonstrated acceptability and a growing evidence base for the treatment of distress in IBD populations. The present paper trialled two brief ACT interventions via randomized multiple baseline designs. Study 1 trialled a single-session ACT intervention (delivered face-to-face and lasting approximately two hours) targeting stress and experiential avoidance, respectively. Participants were seven people with an IBD diagnosis who presented with moderate to extremely severe stress (five females, two males; M age = 39.57, SD = 5.74). The findings of study 1 indicate that a single-session ACT intervention represented an insufficient dosage to reduce stress and experiential avoidance. Study 2 investigated a brief telehealth ACT intervention (delivered via a video conferencing platform and lasting approximately four hours) targeting stress and increased psychological flexibility. Participants (N = 12 people with an IBD diagnosis and mild to extremely severe stress) completed baselines lasting from 21 to 66 days before receiving a two-session ACT telehealth intervention supplemented by a workbook and phone consultation. Approximately half of participants experienced reduced stress, increased engagement in valued action, and increased functioning. Despite shortcomings such as missing data and the context of COVID-19, the present findings suggest that brief ACT interventions in this population may be effective and economic, though further research and replications are necessary.


  • GOOD FOR THE ENVIRONMENT AND THE POCKET– AN AUDIT OF WASTE GENERATION AND RECYCLING PRACTICES WITHIN AN IRISH ENDOSCOPY UNIT

    by N. O'MOrain, E. Joy, E. Donohoe, J. Doherty, R. Stack, H. Mulcahy, E. McDermott

    Aims Ireland has one of the highest greenhouse gas emissions per capita in the EU, at 13.3 metric tons of CO2 equivalent/person. Healthcare accounts for 30% of all public sector greenhouse gas emissions. General waste accounts for almost 60% of waste generated in Irish hospitals. It has been estimated that 1/3 of this could be recycled. A large volume of recyclable waste is generated in Endoscopy, however sustainable practices are not currently promoted. This quality improvement project sought to determine the volume of recyclable waste generated within Endoscopy and whether use of green bin would be a cost-effective strategy. Methods Waste generated by patient-related activity over one week was audited. Non-clinical and clinical waste was weighed and sorted, with the percentage of recyclable waste documented and net cost savings calculated. Reduction in carbon dioxide emissions (CO2e) was calculated. Results In total, 70 non-clinical and 56 clinical waste bags were collected. Median weight for non-clinical waste was 20.1kg (IQR 19.7-21.7kg) and 40kg (IQR 28.8-39.0kg) for clinical waste. Median of 14.1kg (70.5%) of non-clinical and 3kg (7.5%) of clinical waste was recyclable. Disposal cost/tonne summarised in [Table 1]. Net savings of €86.5/week was generated, and a reduction in carbon footprint by 21.7kg CO2e. This equates to a cost saving of €4,498 per year ([Figure 1]), and a reduction in CO2e of 1,128.4kg. Conclusions This audit highlights the impact sustainable practices can have on waste management in Endoscopy. A considerable volume of waste generated can be recycled with significant cost savings and reductions in CO2e. Publication Date: 14 April 2022 (online) © 2022. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases

    by Brona Wynne, Louise McHugh, Wei Gao, Denise Keegan, Kathryn Byrne, Catherine Rowan, Karen Hartery, Clemens Kirschbaum, Glen Doherty, Garret Cullen, et al.


  • Open Access

    Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis

    by K. Hartery, S. O'Reilly, D. Houlihan, G. Doherty, H. Mulcahy, G. Cullen, J. Sheridan


  • Mitochondrial mutagenesis induced by tumor-specific radiation bystander effects

    by Sheeona Gorman, Edward Fox, Diarmuid O’dOnoghue, Kieran Sheahan, John Hyland, Hugh Mulcahy, Lawrence A. Loeb, Jacintha O’sUllivan

    The radiation bystander effect is a cellular process whereby cells not directly exposed to radiation display cellular alterations similar to directly irradiated cells. Cellular targets including mitochondria have been postulated to play a significant role in this process. In this study, we utilized the Random Mutation Capture assay to quantify the levels of random mutations and deletions in the mitochondrial genome of bystander cells. A significant increase in the frequency of random mitochondrial mutations was found at 24 h in bystander cells exposed to conditioned media from irradiated tumor explants (p = 0.018). CG:TA mutations were the most abundant lesion induced. A transient increase in the frequency of random mitochondrial deletions was also detected in bystander cells exposed to conditioned media from tumor but not normal tissue at 24 h (p = 0.028). The increase in both point mutations and deletions was transient and not detected at 72 h. To further investigate mitochondrial dysfunction, mitochondrial membrane potential and reactive oxygen species were assessed in these bystander cells. There was a significant reduction in mitochondrial membrane potential and this was positively associated with the frequency of random point mutation and deletions in bystander cells treated with conditioned media from tumor tissue (r = 0.71, p = 0.02). This study has shown that mitochondrial genome alterations are an acute consequence of the radiation bystander effect secondary to mitochondrial dysfunction and suggests that this cannot be solely attributable to changes in ROS levels alone.